
BioLife Solutions showcases its Biologistex service for managing logistics of biologic materials
Company hopes to ride a boom in stem-cell and related therapies
Following a successful debut at the International Soc. for Cellular Therapy (ISCT; Las Vegas, May 27-30), BioLife Solutions says that it is 4-6 weeks away from introducing its
The company has previously announced a partnership with Savsu Technologies (Santa Fe, NM), and will be using Savsu’s Evo shippers, generally with 1-liter capacity and configured for controlled room-temperature, 2-8°C (refrigerated) and cryogenic temperature regimes. Other, unnamed partners are providing related technology, says Mike Rice, BioLife CEO. “The goal is to empower our customers to self-manage the overall logistics process for these materials, without needing to rely on ‘white glove’ courier services and other logistics providers,” he says. The cloud-based apps the company is developing will enable clients not only to monitor the condition of a shipment, but also to select a carrier service and book a shipment.
Rice continues: "We believe that ‘needle to needle’ logistics surveillance, from the extraction of source material from a patient, to the delivery of a manufactured cellular therapeutic to the same or an unrelated patient, not only enhances clinical care, but will also become required by regulators and payers as more biologic-based therapies navigate the approval process and move into largescale commercial manufacturing.”




